Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma

SIMPLE SUMMARY: Chondrosarcomas develop chemoresistance to standard anticancer drugs, making it difficult to control unresectable or metastatic chondrosarcomas. To improve the clinical outcomes of chondrosarcoma, new treatment approaches, such as molecule-targeting agents and immunotherapy, are need...

Descripción completa

Detalles Bibliográficos
Autores principales: Miwa, Shinji, Yamamoto, Norio, Hayashi, Katsuhiro, Takeuchi, Akihiko, Igarashi, Kentaro, Tsuchiya, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834928/
https://www.ncbi.nlm.nih.gov/pubmed/35163019
http://dx.doi.org/10.3390/ijms23031096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834928/
https://www.ncbi.nlm.nih.gov/pubmed/35163019
http://dx.doi.org/10.3390/ijms23031096

Ejemplares similares